In a novel cohort of HCC patients receiving preoperative therapy, including lenvatinib (cohort 2, n = 50) (Fig. 6f), the IHC results indicated that USP14 expression was positively correlated with CIB1 expression in HCC tissues (Fig. 6g). This evidence concerns the gene USP14 and hepatocellular carcinoma.